HealthLynked (OTCQB: HLYK) offers cutting-edge technology and connectivity to provide more efficient, accessible, and personalized healthcare, through centralized and integrated information management and access. Among other things, HealthLynked greatly improves the use and effectiveness of remote patient care, such as telemedicine, telehealth, remote monitoring, and direct-to-consumer lab testing.
At the heart of the system is the HealthLynked Network, the company’s comprehensive and sophisticated cloud-based healthcare platform that securely, efficiently, and cost-effectively connects patients, healthcare providers, and medical facilities. The platform’s offerings include centralizing and securing medical records and data (including personal health records, past surgeries, allergies, and medications), appointment scheduling, telemedicine, patient engagement tools, and more.
“With HealthLynked [Network], patients can easily store and share their medical information with healthcare providers, receive reminders for appointments and preventative care, and access educational resources. Healthcare providers can use the platform to manage patient records, communicate with other providers, and offer telemedicine services. In addition, medical facilities can benefit from the platform’s centralized scheduling and administrative tools, as well as the ability to offer patients a comprehensive suite of services through a single platform,” explains the company’s investor presentation (https://ibn.fm/zpN7z).
Through this sophisticated platform, HealthLynked is changing how patients and medical professionals interact and communicate, including greatly improved telehealth and telemedicine effectiveness. Telehealth, a broad term that captures all forms of healthcare services delivered remotely via technology and connected systems, differs from telemedicine, which refers to a subset of healthcare that only focuses on offering clinical services via technology. Whereas telehealth broadly covers services like health education, mental health services, and other non-clinical interactions, telemedicine only encompasses services offered in a clinical setting via technology, including testing, diagnosing, and medical conditions. HealthLynked Network is a transformative force in telehealth, pushing the boundaries of traditional services and eliminating the barriers that once restricted access to medical services.
Here’s a closer look at how HealthLynked is redefining patient care:
In conclusion, HealthLynked is a transformative force in telehealth, pushing the boundaries of traditional services to deliver comprehensive care. By expanding access and leveraging advanced network capabilities, they are setting a new standard for virtual healthcare, particularly in women’s health and at-home testing.
For more information, visit the company’s website at www.HealthLynked.com.
NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYK
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
The global market for brain tumor treatments is experiencing significant transformation powered by advances in…
A team of researchers has developed a “cost-effective” and simple blood test with the potential…
Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…
Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…
Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…
Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…